Lakefront Biotherapeutics LKFT Cash Flow Statement (2013-2026)

NASDAQ LKFT
$30.75 +0.96 (+3.22%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Lakefront Biotherapeutics Quarterly Cash Flow Statement

Periods 48 quarters
Latest Jun 2026

Lakefront Biotherapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 48 quarters of results from Dec 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2013 Sep2014 Dec2014 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-141.04M18.73M-14.94M-20.26M21.69M-211.40M24.91M5.55M28.13M169.52M98.01M-20.65M-24.45M27.04M-161.36M-119.64M-236.34M910.45M16.97M2.45M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
Depreciation & Amortization (CF)Dep. & Amort.
Share-based CompensationStock Comp.
Deferred Taxes
Gains from Equity InvestmentsGains Equity
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
503.87M
Other non-cash itemsOther Non-Cash
104.46M-103.73M10.83M61.94M-69.97M124.65M-2.60M-0.08M-10.13M18.25M-62.72M-4.67M-6.73M-108.36M-9.58M-36.48M4.76M142.43M-4.15M
Non-cash ItemsNon-Cash Items
Change in Working Capital
Change in ReceivablesChange Receivables
Change in InventoryChange Inventory
Change in Account PayablesChange Payables
Change in Other Operating AssetsOther Assets Change
Change in Other Operating LiabilitiesOther Liabilities Change
-109.34M-66.78M-161.56M-324.72M-89.05M18.24M-147.04M-60.46M-62.44M67.02M-204.31M-1,043.45M
Other Working Capital ChangesOther WC Changes
-109.34M-66.78M-161.56M-324.72M-89.05M18.24M-147.04M-60.46M-62.44M67.02M-204.31M-1,043.45M
Other Operating ActivitiesOther Ops.
0.71M2.63M6.25M37.49M14.62M-67.72M120.74M39.53M5.06M-30.11M51.56M33.72M14.06M
Cash from OperationsCash from Ops.
-69.55M-183.50M-101.83M-71.94M-133.01M-63.44M-40.61M-55.25M-96.88M
Investing Activities
Capital ExpendituresCapex
-445.77M494.43M-112.12M-159.63M-115.55M399.42M-111.09M-226.10M218.62M32.04M-4.07M-3.58M-4.65M29.94M-5.36M-4.70M-3.33M30.04M-0.14M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.02M0.13M26.68M0.45M1.54M
Change in Property, Plant and EquipmentChange in PP&E
445.77M-494.43M112.12M159.63M115.55M-399.40M111.09M226.10M-218.62M-31.91M4.07M3.58M4.65M-29.94M5.36M4.70M30.01M-29.59M1.69M
Divestments
-1.45M-4.17M-5.49M1.35M33.58M-25.12M9.44M1.89M2.74M
Net of Acquisitions & DivestmentsNet Acquisitions
-1.45M-4.17M-5.49M1.35M33.58M-25.12M9.44M1.89M2.74M
Purchase of InvestmentsInvestments Purchased
-1,785.76M-4.00M5,340.30M-1,082.86M6,476.36M-40.07M-1,593.64M-554.06M5,778.46M-357.64M-1,978.10M-1,127.36M7,585.94M-58.71M
Sale and Maturity of InvestmentsInvestments Sold
563.63M252.06M775.10M941.86M531.94M1,321.76M619.86M1,482.11M412.13M2,048.55M1,172.25M559.17M122.93M
Other Investing ActivitiesOther investing
-8.35M2.52M5.28M5.05M5.28M6.54M14.95M8.17M39.13M15.24M-17.38M4.84M
Cash from Investing ActivitiesCash from Investing
-1,047.65M18.48M-309.84M82.21M32.23M71.09M62.11M73.05M89.14M84.57M66.33M84.54M72.00M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
2.42M1.90M
Net Shares Issued and RepurchasedNet Shares Issued
2.42M1.90M
Net Equity Issued and RepurchasedNet Equity Issued
2.42M1.90M
Other financing activitiesOther financing
-2.45M-1.96M-2.10M-1.28M-1.27M-1.15M-1.19M-1.71M-1.06M-0.68M-1.47M-0.47M-0.60M
Cash from Financing ActivitiesCash from Financing
-0.03M-1.96M-0.20M-1.28M-1.27M-1.15M-1.19M-1.71M-1.06M-0.68M-1.47M-0.47M-0.60M
Additional items
Exchange Rate EffectFX Effect
18.36M-3.81M-0.27M-0.98M0.54M0.47M-0.53M1.42M-1.37M-1.95M-0.10M-1.57M0.82M
Change in Cash
-1,117.23M-1,782.93M-411.87M-365.59M-102.05M-1.60M-17.92M-111.51M47.47M-39.25M-8.33M28.82M-25.48M
Ending Cash Balance
2,529.30M2,492.85M2,195.30M541.69M135.36M168.34M184.63M79.20M77.45M62.02M66.85M116.97M84.05M75.62M103.22M76.56M
Free Cash FlowFCF
445.77M-494.43M42.57M159.63M115.55M-582.92M9.27M226.10M-218.62M-103.98M-128.94M3.58M4.65M-93.38M-35.25M4.70M3.33M-85.28M-96.74M
Net Cash FlowNCF
-1,117.23M-166.98M-411.87M8.99M-102.05M69.94M60.92M7.89M47.47M83.89M64.86M28.82M-25.48M
Interest Paid
-4.45M23.88M-3.16M8.11M-0.47M0.60M-0.78M1.37M-0.22M0.58M-0.81M0.99M-0.07M
Income Taxes PaidTaxes Paid
-0.90M8.23M-0.70M16.71M-0.82M-0.31M0.49M0.20M-0.24M-1.17M1.18M0.72M-0.10M

Lakefront Biotherapeutics Cash Flow Statement API

Pull Lakefront Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LKFT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY